Ledger.Open graph →
SEC Form D · Amendment · filed March 25, 2025

Paragon Biosciences Emalex Capital, Inc

Offering
$242.0M
Sold
$217.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CHICACO, IL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Patrick J. Morris · Chicago, ILExecDarien J. Parhad · Chicago, ILExecRicky J. Sun · Chicago, ILDirectorAntonio J. Gracias · Chicago, ILDirectorJeffrey J. Aronin · Chicago, ILDirectorEric J. Messner · Chicago, ILExec · DirectorJeffrey J. Dayno · Chicago, ILDirectorAmit Assaraf · New York, NYExecWilliam D. Rahm · New York, NYExecRicardo Lombardi · New York, NYDirectorRicky J. Sun · Chicago, ILDirectorJeffrey J. Dayno · Chicago, ILDirectorPatrick N. Nolan · Atlanta, GADirectorEric J. Messner · Chicago, ILExec · DirectorKevin Chavers · New York, NYDirectorAl C. Laskaj · NEW YORK, NYDirectorDana C. Devivo · NEW YORK, NYExecFrancis C. Poli · NEW YORK, NYExecJames L. Alt · New York, NYExec · DirectorMichael L. Appel · New York, NYDirectorDavid Tingley · Naples, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗